Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3515.0
(0.14%)
JPY 3515.0
(0.14%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 75.57 Billion | 67.49 Billion | 65.38 Billion | 69.04 Billion | 63.24 Billion | 72.3 Billion |
| Cost of Revenue | 38.23 Billion | 35.11 Billion | 34.14 Billion | 36.32 Billion | 28.34 Billion | 26.73 Billion |
| Gross Profit | 37.34 Billion | 32.37 Billion | 31.23 Billion | 32.72 Billion | 34.9 Billion | 45.56 Billion |
| Operating Expenses | 33.32 Billion | 33.5 Billion | 32.64 Billion | 31.21 Billion | 33.04 Billion | 39.36 Billion |
| Selling, General and Administrative Expenses | 20.79 Billion | 20.3 Billion | 19.92 Billion | 19.6 Billion | 21.13 Billion | 22.57 Billion |
| Research and Development Expenses | 9.47 Billion | 10.39 Billion | 10.36 Billion | 9.62 Billion | 10.76 Billion | 15.71 Billion |
| Other Expenses | - | 58 Million | 281 Million | 131 Million | 171 Million | 93 Million |
| Cost and Expenses | 71.56 Billion | 68.62 Billion | 66.78 Billion | 67.53 Billion | 61.38 Billion | 66.09 Billion |
| Operating Income | 4.01 Billion | -1.12 Billion | -1.4 Billion | 1.5 Billion | 1.85 Billion | 6.2 Billion |
| Interest Expense | 18 Million | 20 Million | 23 Million | 23 Million | 23 Million | 23 Million |
| Income Tax Expense | 3.15 Billion | 3.04 Billion | 3.47 Billion | 2.09 Billion | 1.74 Billion | 1.58 Billion |
| Earnings before Tax | 14.44 Billion | 13.68 Billion | 16.5 Billion | 7.47 Billion | 4.63 Billion | 7.12 Billion |
| Net Income | 11.16 Billion | 10.52 Billion | 12.92 Billion | 5.28 Billion | 2.81 Billion | 5.48 Billion |
| Earnings Per Share Basic | 246.58 | 228.30 | 280.19 | 113.25 | 60.30 | 117.33 |
| Earnings Per Share Diluted | 246.58 | 228.30 | 280.19 | 113.25 | 60.30 | 117.33 |
| Weighted Average Shares Outstanding | 45.25 Million | 46.11 Million | 46.11 Million | 46.66 Million | 46.71 Million | 46.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.25 Million | 46.11 Million | 46.11 Million | 46.66 Million | 46.71 Million | 46.71 Million |
| Gross Margin | 0.49 | 0.48 | 0.48 | 0.47 | 0.55 | 0.63 |
| EBIT Margin | 0.25 | 0.07 | 0.06 | 0.09 | 0.09 | 0.14 |
| Profit Margin | 0.15 | 0.16 | 0.20 | 0.08 | 0.04 | 0.08 |
| EBITDA | 18.72 Billion | 17.8 Billion | 20.26 Billion | 10.64 Billion | 7.21 Billion | 9.75 Billion |
| Earnings Before Tax Margin | 0.05 | -0.02 | -0.02 | 0.02 | 0.03 | 0.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 21.3 Billion | 21.16 Billion | 17.72 Billion | 75.57 Billion | 20.88 Billion | 17.66 Billion |
| Cost of Revenue | 10.78 Billion | 10.28 Billion | 8.94 Billion | 41.15 Billion | 10.61 Billion | 8.94 Billion |
| Gross Profit | 10.51 Billion | 10.88 Billion | 8.77 Billion | 34.42 Billion | 10.26 Billion | 8.71 Billion |
| Operating Expenses | -10.89 Billion | 6 Billion | 8.92 Billion | 30.4 Billion | 8.11 Billion | 8.33 Billion |
| Selling, General and Administrative Expenses | - | 8.72 Billion | 6.21 Billion | - | 5.85 Billion | 6.03 Billion |
| Research and Development Expenses | - | 2.58 Billion | 2.71 Billion | - | 2.26 Billion | 2.29 Billion |
| Other Expenses | -10.89 Billion | - | 17 Million | -143 Million | 2 Million | -1 Million |
| Cost and Expenses | 21.67 Billion | 16.29 Billion | 17.86 Billion | 71.56 Billion | 18.73 Billion | 17.28 Billion |
| Operating Income | -376 Million | 2.15 Billion | -148 Million | 4.01 Billion | 2.14 Billion | 382 Million |
| Interest Expense | - | 4 Million | 5 Million | 18 Million | 4 Million | 5 Million |
| Income Tax Expense | 490 Million | 1.41 Billion | 511 Million | 3.15 Billion | 903 Million | 720 Million |
| Earnings before Tax | 1.63 Billion | 5.52 Billion | 3.34 Billion | 14.44 Billion | 3.59 Billion | 3.15 Billion |
| Net Income | 1.14 Billion | 4.1 Billion | 2.82 Billion | 11.16 Billion | 2.65 Billion | 2.41 Billion |
| Earnings Per Share Basic | 25.86 | 92.88 | 63.80 | - | 59.17 | 52.67 |
| Earnings Per Share Diluted | - | 92.88 | 63.80 | - | 59.17 | 52.67 |
| Weighted Average Shares Outstanding | - | 44.2 Million | 44.24 Million | 45.25 Million | 44.93 Million | 45.81 Million |
| Weighted Average Shares Outstanding (Diluted) | - | 44.2 Million | 44.24 Million | 45.25 Million | 44.93 Million | 45.81 Million |
| Gross Margin | 0.49 | 0.51 | 0.50 | 0.46 | 0.49 | 0.49 |
| EBIT Margin | 0.04 | 0.15 | 0.06 | - | 0.13 | 0.03 |
| Profit Margin | 0.05 | 0.19 | 0.16 | 0.15 | 0.13 | 0.14 |
| EBITDA | 785 Million | 3.22 Billion | 990 Million | - | 2.65 Billion | 459 Million |
| Earnings Before Tax Margin | -0.02 | 0.10 | -0.01 | 0.05 | 0.10 | 0.02 |
8034
AMUN
UAMA
AVROIND
JUBLINGREA
XRX